Dong-Sheng Pei (Dongsheng Pei)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

Long Noncoding Rna

Top Venues

Cell death & disease

Cellular & molecular biology letters

Clinical and translational medicine

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Xin Jiang, Zhiman Zhu, Lina Ding, Wenqi Du, Dong-Sheng Pei
ALKBH4 impedes 5-FU Sensitivity through suppressing GSDME induced pyroptosis in gastric cancer. Cell death & disease 15 (6) (2024)
Xu Sun, Ce Shi, Jin Dai, Mei-Qing Zhang, Dong-Sheng Pei, Lei Yang
Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo. Cell death & disease 15 (5) (2024)
Xu Sun, Ce Shi, Jin Dai, Mei-Qing Zhang, Dong-Sheng Pei, Lei Yang
Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo. Cell death & disease 15 (5) (2024)
Xin Jiang, Zhiman Zhu, Lina Ding, Wenqi Du, Dong-Sheng Pei
ALKBH4 impedes 5-FU Sensitivity through suppressing GSDME induced pyroptosis in gastric cancer. Cell death & disease 15 (6) (2024)
Wenqi Du, Xin Quan, Chaoqun Wang, Qiuya Song, Jie Mou, Dong-Sheng Pei
Regulation of tumor metastasis and CD8 + T cells infiltration by circRNF216/miR-576-5p/ZC3H12C axis in colorectal cancer. Cellular & molecular biology letters 29 (1) (2024)
Wenqi Du, Xin Quan, Chaoqun Wang, Qiuya Song, Jie Mou, Dong-Sheng Pei
Regulation of tumor metastasis and CD8 + T cells infiltration by circRNF216/miR-576-5p/ZC3H12C axis in colorectal cancer. Cellular & molecular biology letters 29 (1) (2024)
Xin Jiang, Zhiman Zhu, Lina Ding, Wenqi Du, Dong-Sheng Pei
ALKBH4 impedes 5-FU Sensitivity through suppressing GSDME induced pyroptosis in gastric cancer. Cell death & disease 15 (6) (2024)
Xin Jiang, Zhiman Zhu, Lina Ding, Wenqi Du, Dong-Sheng Pei
ALKBH4 impedes 5-FU Sensitivity through suppressing GSDME induced pyroptosis in gastric cancer. Cell death & disease 15 (6) (2024)
Xu Sun, Ce Shi, Jin Dai, Mei-Qing Zhang, Dong-Sheng Pei, Lei Yang
Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo. Cell death & disease 15 (5) (2024)
Wenqi Du, Xin Quan, Chaoqun Wang, Qiuya Song, Jie Mou, Dong-Sheng Pei
Regulation of tumor metastasis and CD8 + T cells infiltration by circRNF216/miR-576-5p/ZC3H12C axis in colorectal cancer. Cellular & molecular biology letters 29 (1) (2024)
Xu Sun, Ce Shi, Jin Dai, Mei-Qing Zhang, Dong-Sheng Pei, Lei Yang
Targeting the mitochondrial protein YME1L to inhibit osteosarcoma cell growth in vitro and in vivo. Cell death & disease 15 (5) (2024)
Bowen Liu, Angxi Song, Pengkun Gui, Jin Wang, Yaojie Pan, Chao Li, Shuai Li, Yi Zhang, Tao Jiang, Yixin Xu, Dong-Sheng Pei, Jun Song
Long noncoding RNA LINC01594 inhibits the CELF6-mediated splicing of oncogenic CD44 variants to promote colorectal cancer metastasis. Cell death & disease 14 (7) (2023)
Zhi-Man Zhu, Fu-Chun Huo, Jian Zhang, Hong-Jian Shan, Dong-Sheng Pei
Crosstalk between m6A modification and alternative splicing during cancer progression. Clinical and translational medicine 13 (10) (2023)
Fu-Chun Huo, Zhi-Man Zhu, Qiu-Ying Du, Dong-Sheng Pei
PAK5-stabilized Smuc confers renal cell carcinoma metastasis. Clinical and translational medicine 11 (9) (2022)
Wenqi Du, Ruicheng Zhang, Bilal Muhammad, Dong-Sheng Pei
Targeting the COP9 signalosome for cancer therapy. Cancer biology & medicine (2022)
Yao-Jie Pan, Bo-Wen Liu, Dong-Sheng Pei
The Role of Alternative Splicing in Cancer: Regulatory Mechanism, Therapeutic Strategy, and Bioinformatics Application. DNA and cell biology 41 (9) (2022)
Qiu-Ying Du, Fu-Chun Huo, Wen-Qi Du, Xiao-Lin Sun, Xin Jiang, Lan-Sheng Zhang, Dong-Sheng Pei
METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA. Oncogene 41 (39) (2022)
Yao-Jie Pan, Fu-Chun Huo, Meng-Jie Kang, Bo-Wen Liu, Meng-Di Wu, Dong-Sheng Pei
Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer. Clinical and translational medicine 12 (11) (2022)
Man-Ru Liu, Wen-Tao Zhu, Dong-Sheng Pei
System Xc-: a key regulatory target of ferroptosis in cancer. Investigational new drugs 39 (4) (2021)
Min Xie, Dong-Sheng Pei
Serine hydroxymethyltransferase 2: a novel target for human cancer therapy. Investigational new drugs 39 (6) (2021)
Tong-Tong Li, Jie Mou, Yao-Jie Pan, Fu-Chun Huo, Wen-Qi Du, Jia Liang, Yang Wang, Lan-Sheng Zhang, Dong-Sheng Pei
MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway. Journal of biomedical science 28 (1) (2021)
Xiao-Jin Wu, Yuan-Yuan Chen, Wen-Wen Guo, Tao Li, Hai-Bei Dong, Wei Wang, Min Xie, Gao-Lei Ma, Dong-Sheng Pei
HMGB1 regulates SNAI1 during NSCLC metastasis, both directly, through transcriptional activation, and indirectly, in a RSF1-IT2-dependent manner. Molecular oncology 14 (6) (2020)
Fu-Chun Huo, Zhi-Man Zhu, Dong-Sheng Pei
N6 -methyladenosine (m6 A) RNA modification in human cancer. Cell proliferation 53 (11) (2020)
Tong-Tong Li, Man-Ru Liu, Dong-Sheng Pei
Friend or foe, the role of EGR-1 in cancer. Medical oncology (Northwood, London, England) 37 (1) (2019)
Xiaojin Wu, Weitao Wang, Yuanyuan Chen, Xiangqun Liu, Jindong Wang, Xiaobin Qin, Dawei Yuan, Tao Yu, Guangxia Chen, Yanyan Mi, Jie Mou, Jinpeng Cui, Ankang Hu, Yunxiang E, Dong-Sheng Pei
High Mobility Group Box Protein 1 Serves as a Potential Prognostic Marker of Lung Cancer and Promotes Its Invasion and Metastasis by Matrix Metalloproteinase-2 in a Nuclear Factor-κB-Dependent Manner. BioMed research international 2018 (2018)
Xiaojin Wu, Weitao Wang, Yuanyuan Chen, Xiangqun Liu, Jindong Wang, Xiaobin Qin, Dawei Yuan, Tao Yu, Guangxia Chen, Yanyan Mi, Jie Mou, Jinpeng Cui, Ankang Hu, Yunxiang E, Dong-Sheng Pei
Glycyrrhizin Suppresses the Growth of Human NSCLC Cell Line HCC827 by Downregulating HMGB1 Level. BioMed research international 2018 (2018)
Xiao-Jin Wu, Yuan-Yuan Chen, Chan-Chan Gong, Dong-Sheng Pei
The role of high-mobility group protein box 1 in lung cancer. Journal of cellular biochemistry 119 (8) (2018)